Advertisement
Research| Volume 4, ISSUE 7, P945-957, July 2005

“Subcellular Proteomics” of Neuromelanin Granules Isolated from the Human Brain*

  • Florian Tribl
    Correspondence
    Recipient of the Ph.D. scholarship DOC from the Austrian Academy of Sciences. To whom correspondence should be addressed. Tel.: 49-931-201-77300; Fax: 49-931-201-77220;
    Affiliations
    Department of Clinical Neurochemistry, Clinic and Polyclinic for Psychiatry and Psychotherapy, and “The National Parkinson Foundation Research Laboratories, ” Miami, Florida, at the Bayerische Julius-Maximilians-Universität Würzburg, Füchsleinstrasse 15, 97080 Würzburg

    Institute of Organic Chemistry, Bayerische Julius-Maximilians-Universität Würzburg, Am Hubland, 97074 Würzburg, Germany
    Search for articles by this author
  • Manfred Gerlach
    Affiliations
    Department of Clinical Neurochemistry, Clinic and Polyclinic for Child and Adolescent Psychiatry and Psychotherapy, Bayerische Julius-Maximilians-Universität Würzburg, Füchsleinstrasse 15, 97080 Würzburg
    Search for articles by this author
  • Katrin Marcus
    Affiliations
    Medical Proteome Center, Ruhr-Universität Bochum, Universitätsstrasse 150, 44780 Bochum
    Search for articles by this author
  • Esther Asan
    Affiliations
    Institute of Anatomy and Cell Biology, Bayerische Julius-Maximilians-Universität Würzburg, Koellikerstrasse 6, 97970 Würzburg
    Search for articles by this author
  • Thomas Tatschner
    Affiliations
    Institute of Forensic Medicine, Bayerische Julius-Maximilians-Universität Würzburg, Versbacher Strasse 3, 97078 Würzburg
    Search for articles by this author
  • Author Footnotes
    ‖‖ Present address: Inst. of Neuropathology, Ludwig-Maximilians-Universität, Feodor-Lynen-Strasse 23, 81377 Munich, Germany.
    Thomas Arzberger
    Footnotes
    ‖‖ Present address: Inst. of Neuropathology, Ludwig-Maximilians-Universität, Feodor-Lynen-Strasse 23, 81377 Munich, Germany.
    Affiliations
    Institute of Pathology, Bayerische Julius-Maximilians-Universität Würzburg, Josef-Schneider-Strasse 2, 97080 Würzburg
    Search for articles by this author
  • Helmut E. Meyer
    Affiliations
    Medical Proteome Center, Ruhr-Universität Bochum, Universitätsstrasse 150, 44780 Bochum
    Search for articles by this author
  • Gerhard Bringmann
    Affiliations
    Institute of Organic Chemistry, Bayerische Julius-Maximilians-Universität Würzburg, Am Hubland, 97074 Würzburg, Germany
    Search for articles by this author
  • Peter Riederer
    Affiliations
    Department of Clinical Neurochemistry, Clinic and Polyclinic for Psychiatry and Psychotherapy, and “The National Parkinson Foundation Research Laboratories, ” Miami, Florida, at the Bayerische Julius-Maximilians-Universität Würzburg, Füchsleinstrasse 15, 97080 Würzburg
    Search for articles by this author
  • Author Footnotes
    ‖‖ Present address: Inst. of Neuropathology, Ludwig-Maximilians-Universität, Feodor-Lynen-Strasse 23, 81377 Munich, Germany.
    * This work was supported by the BrainNet Europe II and the BMBF Project “Human Brain Proteome Project” (HUPO) and by BMBF Grant 031U102F, the Deutsche Parkinson Vereinigung, and the Fond der Chemischen Industrie (to G. B.) This research was completed within “The National Parkinson Foundation Center of Excellence Research Laboratories,” Miami, Florida, at the Clinic and Polyclinic for Psychiatry and Psychotherapy of the University of Würzburg (awarded to P. R.).
Open AccessPublished:April 25, 2005DOI:https://doi.org/10.1074/mcp.M400117-MCP200
      “Subcellular proteomics” is currently the most effective approach to characterize subcellular compartments. Based on the powerful combination of subcellular fractionation and protein identification by LC-MS/MS we were able for the first time to 1) isolate intact neuromelanin granules from the human brain and 2) establish the first protein profile of these granules. This compartment containing neuromelanin (NM) is primarily located in the primate’s substantia nigra, one of the main brain regions that severely degenerates in Parkinson disease. We used mechanic tissue disaggregation, discontinuous sucrose gradient centrifugation, cell disruption, and organelle separation to isolate NM granules from human substantia nigra. Using transmission electron microscopy we demonstrated that the morphological characteristics of the isolated NM granules are similar to those described in human brain tissue. Fundamentally we found numerous proteins definitely demonstrating a close relationship of NM-containing granules with lysosomes or lysosome-related organelles originating from the endosome-lysosome lineage. Intriguingly we further revealed the presence of endoplasmic reticulum-derived chaperones, especially the transmembrane protein calnexin, which recently has been located in lysosome-related melanosomes and has been suggested to be a melanogenic chaperone.
      Melanins are widely distributed throughout the plant and animal kingdoms. In humans, these heterogeneous, complex polymer pigments occur naturally in the hair, the skin, the inner ear, the iris, and the choroid of the eye (
      • Prota G.
      Melanins and Melanogenesis.
      ). Melanin in the brain has an appearance and structure similar to cutaneous melanins and has thus been named neuromelanin (NM)
      The abbreviations used are: NM, neuromelanin; SN, substantia nigra pars compacta; 1-D, one-dimensional; LAMP, lysosome-associated membrane glycoprotein; GNA, Galanthus nivalis agglutinin; LIMP, lysosome membrane protein; ER, endoplasmic reticulum; Tricine, N-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]glycine; EEA1, early endosomal antigen 1; SNAP, soluble N-ethylmaleimide-sensitive factor (NSF) attachment protein; AP, adaptor-related protein complex; BiP, polypeptide-binding protein.
      1The abbreviations used are: NM, neuromelanin; SN, substantia nigra pars compacta; 1-D, one-dimensional; LAMP, lysosome-associated membrane glycoprotein; GNA, Galanthus nivalis agglutinin; LIMP, lysosome membrane protein; ER, endoplasmic reticulum; Tricine, N-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]glycine; EEA1, early endosomal antigen 1; SNAP, soluble N-ethylmaleimide-sensitive factor (NSF) attachment protein; AP, adaptor-related protein complex; BiP, polypeptide-binding protein.
      (
      • Lillie R.D.
      Metal reduction reactions of the melanins: histochemical studies.
      ). NM is found inter alia in dopaminergic neurons of a small area in the human midbrain important for the control of movement that is known as the substantia nigra pars compacta (SN; from the Latin meaning “black body”). The loss of this dark pigment and the resulting pallor of the SN is one of the most striking features of the common movement disorder Parkinson disease. A relationship between the loss of the dopaminergic SN cells and their NM content (
      • Hirsch E.
      • Graybiel A.M.
      • Agid Y.A.
      Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson’s disease.
      ), a specific affinity to iron (
      • Jellinger K.
      • Kienzl E.
      • Rumpelmair G.
      • Riederer P.
      • Stachelberger H.
      • Ben-Shachar D.
      • Youdim M.B.
      Iron-melanin complex in substantia nigra of parkinsonian brains: an x-ray microanalysis.
      ), and a significant binding of α-synuclein to NM in the diseased state (
      • Fasano M.
      • Giraudo S.
      • Coha S.
      • Bergamasco B.
      • Lopiano L.
      Residual substantia nigra neuromelanin in Parkinson’s disease is cross-linked to α-synuclein.
      ) suggest a functional role for NM in neurodegeneration in Parkinson disease (
      • Double K.L.
      • Ben-Shachar D.
      • Youdim M.B.
      • Zecca L.
      • Riederer P.
      • Gerlach M.
      Influence of neuromelanin on oxidative pathways within the human substantia nigra.
      ).
      Although much is known about the peripheral melanins to which NM is thought to be related, many basic questions remain to be answered about NM in the brain. Thus it is unclear why only some human dopamine neurons produce NM within their cytoplasm (
      • McRitchie D.A.
      • Halliday G.M.
      • Cartwright H.
      Quantitative analysis of the variability of substantia nigra pigmented cell clusters in the human.
      ). Little is also known about the structure of NM, and the understanding of its genesis and function within the cell remains speculative.
      Nuclear magnetic resonance spectroscopic studies have shown that NM resembles synthetic cysteinyldopamine melanin more closely than the more simple dopamine melanin; however, human NM appears to be a structurally more complex chemical structure than any of the synthetic models (
      • Double K.L.
      • Zecca L.
      • Costi P.
      • Mauer M.
      • Griesinger C.
      • Ito S.
      • Ben-Shachar D.
      • Bringmann G.
      • Fariello R.G.
      • Riederer P.
      • Gerlach M.
      Structural characteristics of human substantia nigra neuromelanin and synthetic dopamine melanins.
      ). In addition to the melanin backbone, nuclear magnetic resonance spectroscopic studies have demonstrated that cholesterol and other uncharacterized high molecular mass lipid components are closely associated with NM (
      • Double K.L.
      • Zecca L.
      • Costi P.
      • Mauer M.
      • Griesinger C.
      • Ito S.
      • Ben-Shachar D.
      • Bringmann G.
      • Fariello R.G.
      • Riederer P.
      • Gerlach M.
      Structural characteristics of human substantia nigra neuromelanin and synthetic dopamine melanins.
      • Dzierzega-Lecznar A.
      • Kurkiewicz S.
      • Stepien K.
      • Chodurek E.
      • Wilczok T.
      • Arzberger T.
      • Riederer P.
      • Gerlach M.
      GC/MS analysis of thermally degraded neuromelanin from the human substantia nigra.
      • Zecca L.
      • Costi P.
      • Mecacci C.
      • Ito S.
      • Terreni M.
      • Sonnino S.
      Interaction of human substantia nigra neuromelanin with lipids and peptides.
      ). Dolichol was identified as the major lipid component of NM (
      • Fedorow H.
      • Pickford R.
      • Hook J.M.
      • Double K.L.
      • Halliday G.M.
      • Gerlach M.
      • Riederer P.
      • Garner B.
      Dolichol is the major lipid component of human substantia nigra neuromelanin.
      ). A proteinaceous component making up ∼5–15% of the isolated molecule is also present that has been suggested to represent an integral component of the polymer (
      • Double K.L.
      • Zecca L.
      • Costi P.
      • Mauer M.
      • Griesinger C.
      • Ito S.
      • Ben-Shachar D.
      • Bringmann G.
      • Fariello R.G.
      • Riederer P.
      • Gerlach M.
      Structural characteristics of human substantia nigra neuromelanin and synthetic dopamine melanins.
      ,
      • Zecca L.
      • Costi P.
      • Mecacci C.
      • Ito S.
      • Terreni M.
      • Sonnino S.
      Interaction of human substantia nigra neuromelanin with lipids and peptides.
      ).
      A general understanding of neuromelanogenesis could be provided by investigation of the synthetic pathway of peripheral melanins and comparison with what is known about NM. Genetic and enzymatic regulation of melanin production in the periphery has been primarily characterized by the study of fur pigmentation in the mouse. Similar experiments, however, cannot be used to elucidate the pathway of NM synthesis as NM does not occur in rodents. It has long been debated whether the NM synthesis is enzymatically controlled, like all melanins in the periphery, or whether NM arises from a simple autoxidation process (for reviews, see Refs.
      • Fedorow H.
      • Tribl F.
      • Halliday G.
      • Gerlach M.
      • Riederer P.
      • Double K.L.
      Neuromelanin in human dopamine neurons: comparison with peripheral melanins and relevance to Parkinson’s disease.
      and
      • Zecca L.
      • Tampellini D.
      • Gerlach M.
      • Riederer P.
      • Fariello R.G.
      • Sulzer D.
      Substantia nigra neuromelanin: structure, synthesis, and molecular behaviour.
      ). In the apparent absence of a role for tyrosinase in neuromelanogenesis, the search for an enzyme associated with NM production has yielded no likely candidates to date (
      • Fedorow H.
      • Tribl F.
      • Halliday G.
      • Gerlach M.
      • Riederer P.
      • Double K.L.
      Neuromelanin in human dopamine neurons: comparison with peripheral melanins and relevance to Parkinson’s disease.
      ,
      • Zecca L.
      • Tampellini D.
      • Gerlach M.
      • Riederer P.
      • Fariello R.G.
      • Sulzer D.
      Substantia nigra neuromelanin: structure, synthesis, and molecular behaviour.
      ). It is noteworthy that Parkinson disease patients treated with large quantities of the dopamine precursor l-3,4-dihydroxyphenylalanine (l-DOPA, levodopa) do not exhibit increased quantities of NM within their surviving SN neurons as might be expected to be the case if NM represents a product of pure dopamine autoxidation. The time course of NM appearance also supports the hypothesis that NM synthesis is a regulated process. In the human, NM is not present in functional dopaminergic neurons at birth but first appears at around 3–5 years of age.
      Although containing a melanin, neuronal NM granules are organelles different from melanosomes, which are mainly localized in melanocytes. In contrast to NM, skin- and hair-based melanins are contained within discrete regularly sized membrane-bound organelles called melanosomes, which differ structurally depending on which type of melanin they contain. It has been suggested that melanosomes are closely related to lysosomes (
      • Basrur V.
      • Yang F.
      • Kushimoto T.
      • Higashimoto Y.
      • Yasumoto K.
      • Valencia J.
      • Muller J.
      • Vieira W.D.
      • Watabe H.
      • Shabanowitz J.
      • Hearing V.J.
      • Hunt D.F.
      • Appella E.
      Proteomic analysis of early melanosomes: identification of novel melanosomal proteins.
      ). In contrast, NM is bordered indistinctly, and the NM granules, as they are called, exhibit a wider size range than that of melanosomes (0.5- 2.5 μm) (
      • Duffy P.E.
      • Tennyson V.M.
      Phase and electron microscopic observations of Lewy bodies and melanin granules in the substantia nigra and locus caeruleus in Parkinson’s disease.
      ,
      • Moses H.L.
      • Ganote C.E.
      • Beaver D.L.
      • Schuffman S.S.
      Light and electron microscopic studies of pigment in human and rhesus monkey substantia nigra and locus coeruleus.
      ). The structurally segregated lipid component of NM that is not found in peripheral melanin pigments has been suggested to originate from the lipid-containing pigment lipofuscin, which also accumulates intracellularly with age (
      • Barden H.
      The histochemical relationship of neuromelanin and lipofuscin.
      ).
      Here we report a method to isolate intact, highly pure NM granules from human SN for subcellular proteomics. Proteomics is the large scale study of gene expression at the protein level that ultimately provides direct measurement of protein expression levels and insight into the activity state of all relevant proteins (
      • Aebersold R.
      • Mann M.
      Mass spectrometry-based proteomics.
      • Binz P.A.
      • Hochstrasser D.F.
      • Appel R.D.
      Mass spectrometry-based proteomics: current status and potential use in clinical chemistry.
      • Jung E.
      • Heller M.
      • Sanchez J.C.
      • Hochstrasser D.F.
      Proteomics meets cell biology: the establishment of subcellular proteomes.
      ). Subcellular proteomics thus is a powerful approach to gain new insight into functional properties of isolated organelles. We applied one-dimensional (1-D) SDS-PAGE, tryptic in-gel digestion, and nano-LC separation followed by ESI-MS/MS for protein analysis. Following this approach, we identified numerous proteins specific for organelles originating from the endosome-lysosome lineage.

      EXPERIMENTAL PROCEDURES

      Isolation of NM Granules Using Subcellular Fractionation—

      We used a sequential top-down approach that simultaneously allows the reduction of the complexity of the sample and the enrichment of the target structures at each isolation stage. Fig. 1 schematically summarizes the approach chosen. Brains were provided from the Austro-German Brain Bank in Würzburg. The use of postmortem human brain tissue was approved by the Ethics Committee of the University Clinics of Würzburg. The SN was dissected from postmortem brains of subjects with no history of neurological or neurodegenerative diseases within 36 h of death on a cool plate (−15 °C). 1.0 g of frozen SN tissue was thawed in “Separation Buffer” (10 mm HEPES, 10% glucose, pH 6) on ice and carefully passed through a polypropylene mesh into a Petri dish. The whole procedure was performed on a plate cooler set at 4 °C. The resulting cell suspension was layered on top of a discontinuous sucrose gradient (1, 1.2, 1.4, and 1.6 m) and separated by centrifugation at 4000 × g at 4 °C for 15 min. The pelleted dark cell bodies were recovered and washed with “Isolation Buffer” (10 mm HEPES, 1 mm EDTA, 100 mm KCl, 10% sucrose, pH 7.5) containing a protease inhibitor mixture (0.01% (v/v), Sigma). Subsequently the cell disruption was carried out by 10 passages through a 26-gauge needle to yield a suspension of cellular organelles that was layered on top of an 80% (v/v) Percoll cushion (Fluka, Buchs, Switzerland) and centrifuged at 4000 × g at 4 °C for 10 min. The pelleted dark granules were washed once with Isolation Buffer and twice with “Washing Buffer” (10 mm HEPES, 250 mm NaCl, 0.01% (v/v) Triton X-100, pH 7.5) to remove unspecifically associated proteins. The isolated NM granules were stored at −80 °C until analyzed.
      Figure thumbnail gr1
      Fig. 1.Outline of isolation of neuromelanin from human SN. The isolation procedure includes two consecutive steps. In the first step the tissue is disaggregated leading to the enrichment of pigmented neuronal cell bodies after centrifugation through a discontinuous sucrose gradient. In the second step, these pigmented cell bodies are disrupted and subjected to subcellular fractionation to yield NM granules.

      Transmission Electron Microscopy—

      The quality of the granule isolation and the preservation of the ultrastructural features were monitored by transmission electron microscopy. The aspect of cell homogenates and isolated NM granules were compared as a control to monitor the enrichment of the granules. The samples were fixed overnight in 2% (v/v) glutardialdehyde in 0.1 m phosphate-buffered saline, pH 7.4, at 4 °C and incubated in 2% OsO4, 1,5% (v/v) glutardialdehyde followed by dehydration with increasing concentrations of ethanol. After incubation in 1,2-epoxypropane (Sigma) (2 × 15 min) the samples were embedded in EPON™ epoxy resin (Sigma). Following polymerization at 65 °C (48 h) thin sections were prepared that were contrasted with lead citrate and uranyl acetate (
      • Reynolds E.S.
      The use of lead citrate at high pH as an electron-opaque stain in electron microscopy.
      ) before being monitored under the transmission electron microscope (LEO 912 AB, LEO Elektronenmikroskopie, Oberkochen, Germany).

      Sample Preparation for 1-D SDS-PAGE—

      Proteins of isolated NM granules were extracted with 16 mm 3-[(3-cholamidopropyl)dimethylamino]-1-propanesulfonate and SDS, mixed with reducing sample buffer containing dl-dithiothreitol, and heated for 10 min at 95 °C.

      1-D SDS-PAGE—

      The protein samples were separated electrophoretically on 10–20% Tricine gels (Novex, San Diego, CA) in an XCell II™ Mini-Cell (Invitrogen) using Tricine-SDS running buffer. Following electrophoresis the gel was either stained with colloidal Coomassie Brilliant Blue G-250 (
      • Neuhoff V.
      • Arold N.
      • Taube D.
      • Ehrhardt W.
      Improved staining of proteins in polyacrylamide gels including isoelectric focusing gels with clear background at nanogram sensitivity using Coomassie Brilliant Blue G-250 and R-250.
      ) or further processed for Western blotting.

      Antibodies and Materials—

      For Western blot analysis anti-human monoclonal antibodies to cis-Golgi matrix protein (GM130), induced myeloid leukemia cell differentiation protein (Mcl-1), early endosomal antigen 1 (EEA1), integrin α2 (VLA-2α), nucleoporin p62, lysosome-associated membrane glycoprotein 1 (LAMP-1), clathrin, and 78-kDa glucose-regulated protein (BiP/grp78) were used (BD Biosciences). Anti-human monoclonal antibody to dynamin was purchased from Santa Cruz Biotechnology Inc. (Heidelberg, Germany). Anti-human antibodies to calnexin and cathepsin B were purchased from Calbiochem. Biotinylated Galanthus nivalis agglutinin (GNA) and horseradish peroxidase-linked streptavidin were obtained from Vector Laboratories Inc. (Burlingame, CA).

      Tissue Homogenate—

      To provide a positive control for the Western blot analysis, 0.5 g of SN tissue was disrupted using a Potter-Elvehjem homogenizer in Lysis Buffer containing protease inhibitor mixture (0.01%, v/v), and proteins were extracted with 16 mm 3-[(3-cholamidopropyl)dimethylamino-1-propanesulfonate (Calbiochem).

      Western Blot Analysis—

      The separated proteins were transferred electrophoretically onto nitrocellulose membranes (Invitrogen) using the XCell II blot module. Nonspecific binding was blocked with 5% (w/v) nonfat dried milk, 0.5% (v/v) Tween 20 in Tris-buffered saline, pH 7.3, for 1 h at 20 °C. Immunoblots were probed with primary antibodies at the appropriate dilutions at 4 °C overnight or at room temperature for 1 h. Membranes were washed in Tris-buffered saline containing 0.1% (v/v) Tween 20 (3 × 10 min) followed by incubation with the secondary antibody at 20 °C for 1 h. Additional washing was performed with Tris-buffered saline containing 0.1% (v/v) Tween 20 (3 × 10 min), and the immunocomplexes were visualized by enhanced chemiluminescence (ECL™ system, Boehringer Ingelheim). Stripping of immunoblots for repeated probing was performed by incubating the membranes at 50 °C for 15 min in 100 mm 2-mercaptoethanol, 2% SDS, 62.5 mm Tris-HCl, pH 6.7.

      Detection of Mannosylated Proteins by GNA Lectin—

      The biotinylated GNA lectin was applied to visualize mannosylated proteins (
      • Liao Y.F.
      • Lal A.
      • Moremen K.W.
      Cloning, expression, purification, and characterization of the human broad specificity lysosomal acid α-mannosidase.
      ,
      • Shibuya N.
      • Goldstein I.J.
      • Van Damme E.J.
      • Peumans W.J.
      Binding properties of a mannose-specific lectin from the snowdrop (Galanthus nivalis) bulb.
      ) of isolated NM granules and total SN tissue homogenate. The proteins were transferred electrophoretically onto polyvinylidene difluoride membranes (Invitrogen) using the XCell II blot module. The membranes were blocked with Tris-buffered saline containing 0.1% (v/v) Tween 20 at 20 °C for 1 h and incubated with biotinylated GNA lectin overnight at 4 °C followed by incubation with horseradish peroxidase-linked streptavidin at 20 °C for 1 h. The bands of mannosylated proteins were visualized by enhanced chemiluminescence (ECL system).

      In-gel Digestion with Trypsin—

      An entire lane of a gel previously stained with colloidal Coomassie Brilliant Blue G-250 was sliced into 4-mm cubes, and each of these was placed into a separate quartz reaction tube (Sigma) (
      • Schafer H.
      • Nau K.
      • Sickmann A.
      • Erdmann R.
      • Meyer H.E.
      Identification of peroxisomal membrane proteins of Saccharomyces cerevisiae by mass spectrometry.
      ). The gel cubes were washed three times with 10 mm NH4HCO3, pH 7.8, and 10 mm NH4HCO3, pH 7.8, acetonitrile (1:1, v/v) each for 10 min. The gel cubes were subsequently reswollen by addition of 2 μl of modified trypsin (Promega, Madison, WI; 0.05 μg/μl in 10 mm NH4HCO3, pH 7.8). The digestion was performed overnight at 37 °C.

      Sample Preparation for LC Separation—

      10 μl of 0.1% (v/v) trifluoroacetic acid/acetonitrile (1:1, v/v) were added to each gel slice followed by sonication for 10 min. This step was repeated twice, and the supernatants containing the extracted peptides were combined in separate quartz tubes.

      Mass Spectrometric Analysis—

      Nano-HPLC-ESI-MS/MS analysis of the tryptically generated peptides was carried out as described previously (
      • Marcus K.
      • Moebius J.
      • Meyer H.E.
      Differential analysis of phosphorylated proteins in resting and thrombin-stimulated human platelets.
      ). Spectra were recorded on a Finnigan LCQ™ Classic (Thermo Electron, San Jose, CA) ion trap mass spectrometer equipped with a nanoelectrospray ion source (Pico View™ 100, New Objective Inc., Woburn, MA). The peptides were preconcentrated by loading onto a μ-precolumn (0.3-mm inner diameter × 5 mm, PepMap™, LC Packings Dionex, Idstein, Germany) before being separated by reverse-phase nano-LC (75-μm inner diameter × 250 mm, PepMap, LC Packings Dionex) using a precolumn split.

      Mass Spectrometry Data Analysis—

      The analysis of the raw MS/MS data occurred automatically based on the Sequest™ algorithm (
      • Eng J.K.
      • McCormack A.L.
      • Yates III, J.R.
      An approach to correlate tandem mass-spectral data of peptides with amino-acid-sequences in a protein database.
      ,
      • Yates III, J.R.
      • Eng J.K.
      • McCormack A.L.
      • Schieltz D.
      Method to correlate tandem mass spectra of modified peptides to amino acid sequences in the protein database.
      ). The data were searched against the human NCBInr data base (www.ncbi.nlm.nih.gov) using the following parameters: average masses, partial oxidation of methionine (+16 Da), a mass tolerance of ± 1.5 Da, trypsin was used as a specific protease, and a maximum of two missed cleavage sites was tolerated. Furthermore the analysis was restricted to ions in the mass range of 500–5000 Da and a total ion current greater than 3 × 105. In general, a cross correlation value (Xcorr) of greater than 2.0 and a Δ correlation score (ΔCn) greater than 0.1 was accepted for confident identification; inspection of the spectra was performed to confirm the Sequest results.

      RESULTS

      Subcellular Fractionation to Isolate NM-containing Granules—

      We developed a mild procedure for the isolation of intact and pure NM granules from human SN to enable subcellular protein analysis. Fig. 1 shows a schematic summary of the approach used. As a first step, the tissue was disaggregated by mechanical sieving into a cell suspension that was subsequently fractionated by centrifugation through a discontinuous sucrose gradient. This step allowed the enrichment of dark cell bodies as a pellet at the bottom sucrose layer. In the second step, these dark cell bodies were disrupted and subjected to an additional centrifugation step for finally isolating the NM granules by subcellular fractionation.

      Quality Control of Isolated Specimens by Transmission Electron Microscopy—

      The purity and quality of the granule isolation were monitored by transmission electron microscopy to evaluate the level of enrichment achieved by this approach as well as the structural and morphological appearance of the isolated granules (Fig. 2). Compared with the homogenates of pigmented cell bodies prior to the NM granule isolation, the isolated NM granules were virtually free from contaminating organelles; this was attributed to the exceptional density of NM granules. Up to now the essential density to penetrate an 80% (v/v) Percoll cushion has only been reported for highly melanized stage IV melanosomes isolated from Xenopus laevis melanophores (
      • Rogers S.L.
      • Tint I.S.
      • Fanapour P.C.
      • Gelfand V.I.
      Regulated bidirectional motility of melanophore pigment granules along microtubules in vitro.
      ,
      • Testorf M.F.
      • Roback K.
      • Lundstrom I.
      • Svensson S.P.
      Volume changes of individual melanosomes measured by scanning force microscopy.
      ).
      Figure thumbnail gr2
      Fig. 2.Comparative morphological analysis of the organelle preparations to monitor the enrichment of the NM granules. The organelle preparations were fixed in glutardialdehyde and OsO4 and were counterstained with lead citrate and uranyl acetate. Compared with the homogenate of pigmented cell bodies (A and B), according to the second step of the isolation strategy (), NM granules are highly enriched after isolation (C and D).
      Purified granules (Fig. 3) displayed all the morphological structures described previously for primate brain tissue by electron microscopy studies (
      • Moses H.L.
      • Ganote C.E.
      • Beaver D.L.
      • Schuffman S.S.
      Light and electron microscopic studies of pigment in human and rhesus monkey substantia nigra and locus coeruleus.
      ,
      • Hirosawa K.
      Electron microscopic studies on pigment granules in the substantia nigra and locus coeruleus of the Japanese monkey (Macaca fuscata yakui).
      ) showing 1) the highly electron-dense patches attributable to the iron-rich NM, 2) the medium electron-dense protein matrix, and 3) vacuolar lipid bulbs. These characteristics were well preserved during isolation underscoring the potential of this strategy for isolation of NM granules.
      Figure thumbnail gr3
      Fig. 3.The ultrastructural features of the NM granules are well preserved, showing the lobulated form of the granules. Electron-dense regions (arrows) are regarded as the pigment NM; lipid bulbs (arrowheads) are still attached to the granule.

      Quality Control by Western Immunoblotting—

      The level of enrichment was additionally assessed by Western immunoblotting applying antibodies against “marker proteins” specific for cell organelles (Fig. 4A) such as the Golgi network (GM130), mitochondria (Mcl-1), early endosomal compartments (EEA1), the plasma membrane (VLA-2α), the nucleus (nucleoporin p62), lysosomes (cathepsin B and LAMP-1), and the endoplasmic reticulum (BiP/grp78). The proteins extracted from NM granules were compared with control tissue homogenate and show the presence of lysosomal markers, whereas the other “organelle marker proteins” are absent (Fig. 4A, a–e and i).
      Figure thumbnail gr4
      Fig. 4.Quality control by Western immunoblot analysis of proteins extracted from NM granules isolated from human SN compared with SN tissue homogenate.A, the Western immunoblot analysis shows the absence of organelle marker proteins of the Golgi complex (a, cis-Golgi matrix protein 130 (GM130)), mitochondria (a, induced myeloid leukemia cell differentiation protein (Mcl-1)), early endosomal compartments (b, early endosomal antigen 1 (EEA1)), plasma membrane (b, integrin α 2 (VLA-2α)), and nucleus (c, d; nucleoporin p62 (np62)). The protein extract of isolated NM granules compared with SN homogenate shows the presence of cathepsin B (d), a lysosomal proteinase, and LAMP-1 (e), a marker for late endosomes, lysosomes, and lysosome-related organelles. Dynamin (f) and clathrin (g), which are involved in vesicular traffic and are suggested to be associated to endosomal compartments, are detected. The melanogenic chaperone calnexin (h) is present in NM granules, although the marker for the endoplasmic reticulum (i, 78-kDa glucose-regulated protein (BiP/GRP78)) is absent after stripping. B, blotted proteins were probed with GNA lectin, which specifically binds to mannosylated proteins found in lysosomes or lysosome-related organelles.

      Protein Identification by Mass Spectrometry and Western Immunoblotting—

      As depicted in Fig. 5, the proteins extracted from NM granules were further fractionated by 1-D SDS-PAGE into a relatively large number of protein bands, although many of those were poorly resolved. Thus, we cut the entire gel lane into 16 slices and generated peptides from each slice by in-gel digestion with trypsin. These peptides were consequently analyzed in a second dimension by nano-LC coupled to ESI-MS/MS, which gave positive identification of 72 proteins (this experiment was repeated five times with comparable results). The proteins identified by mass spectrometry and the protein characteristics are compiled in Table I. Examples of mass spectral analyses depicting the identification of lysosome integral membrane protein (LIMP) II (Protein 2), subunit A of the vacuolar ATPase (Protein 4), cathepsin D (Protein 8), and calnexin (p90) (Protein 70) are shown in Fig. 6.
      Figure thumbnail gr5
      Fig. 5.Mass spectrometric analysis of proteins extracted from isolated NM granules.A, separation of the proteins by 1-D SDS-PAGE and staining with Coomassie Brilliant Blue G-250. B, the entire gel lane was sliced, and peptides were generated by tryptic “in-gel” digestion. C, a base peak chromatogram as obtained by nano-HPLC coupled to ESI-MS of tryptically generated peptides. mol., molecular; RP, reverse-phase; FA, formic acid.
      Table IProteins identified in NM granules by LC-MS/MS analysis
      Protein no. and nameSwiss-Prot accession numberMolecular mass[Peptides]2+ sequenced; sequence coverageLocationComments
      kDa
      Lysosomal membrane
       1 CD63 antigen (LAMP-3)P0896225.61; 4.2%LyIntegral membrane protein; ocular melanoma-associated antigen
       2 LIMP IIQ1410854.33; 20.9%LyType II membrane protein; may act as a lysosomal receptor
       3 LAMP-1 (CD107a)P1127941.62; 7.1%Ly, ELysosomal and endosomal membrane
       4 V-ATPase, subunit A1P3860668.22; 5.2%LyAcidification of intracellular compartments
       5 V-ATPase, subunit B2P2128158.43; 14.8%LyAcidification of intracellular compartments
       6 V-ATPase, subunit EP3654326.22; 12.0%LyAcidification of intracellular compartments
      Proteases
       7 Cathepsin BP0785828.810; 43.3%LyThiol protease; peptidase family C1
       8 Cathepsin DP0733944.610; 34.2%LyAspartyl protease; peptidase A1
       9
      These proteins were not identified in all five neuromelanin granule preparations.
      Cathepsin Z (contains cathepsins X and Z)
      Q9UBR33.82; 7.9%LyPeptidase family C1
       10 Tripeptidyl-peptidase I (TPP-I; LPIC)O1477361.25; 16.3%LyLysosomal serine protease; peptidase family S53; ceroid lipofuscinosis, neuronal 2, late infantile (CLN2)
       11 γ-Glutamyl hydrolaseQ9282035.911; 52.1%LyLysosomal or secreted; peptidase family C26
       12 Lysosomal Pro-X carboxypeptidase (angiotensinase C)P4278555.83; 9.0%Serine carboxypeptidase; peptidase family S28
       13 Ubiquitin carboxyl-terminal hydrolase 5 (isopeptidase T)Q96J2293.22; 5.3%Ly?Zinc-containing ubiquitin specific protease; peptidase family C19
       14 Dipeptidyl-peptidase II (DPP-II)Q9UHL454.34; 17.8%LyLysosomal and intracellular vesicles; peptidase family S28
      (Glyco)lipid metabolism
       15 Acid ceramidase (acylsphingosine deacylase)Q1351044.614; 46.2%LyHydrolyzes the sphingolipid ceramide into sphingosine and free fatty acid; Farber lipogranulomatosis
       16 Phospholipase D3Q8IV0854.77; 19.7%?
       17 Palmitoyl protein thioesterase 1P5089734.25; 34.2%LyRemoval of thioester-linked fatty acyl groups from modified cysteine residues in proteins; ceroid lipofuscinosis, neuronal 1, infantile (CLN1) and neuronal 4, adult type (CLN4)
       18 β-Hexosaminidase (N-acetyl-β-glucosaminidase)P0768663.14; 17.7%LyDegradation of GM2 gangliosides; Sandhoff disease
       19 GalactosylceramidaseP5480375.12; 4.9%LyLysosomal catabolism of galactosylceramide, a major lipid in myelin; Krabbe disease
       20 Proactivator polypeptide (cerebroside sulfate activator protein)P0760258.53; 6.1%LyContains saposins A, B, C, D; lipid binding and transport; glycosphingolipid metabolism; lysosome organization and biogenesis
      Glycoprotein metabolism
       21 Arylsulfatase B (ARSB)P1584859.71; 3.8%LyDegradation of chondroitin sulfate and dermatan sulfate; mucopolysaccharidosis type VI (MPS-VI, Maroteaux-Lamy syndrome)
       22 N-Acetylgalactosamine-6-sulfatase (chondroitinase)P3405958.04; 16.8%LyDegradation of chondroitin sulfate and dermatan sulfate; mucopolysaccharidosis type IVA (MPS-IVA, Morquio A syndrome)
       23
      These proteins were not identified in all five neuromelanin granule preparations.
      N-Sulfoglucosamine sulfohydrolase (sulfaminase)
      P5168856.73; 13.9%LyDegradation of heparan sulfate; mucopolysaccharidosis type IIIA (MPS-IIIA, Sanfilippo syndrome A)
       24 N4-(β-N-Acetylglucosaminyl)-l-asparaginase (AGA)P2093337.31; 9.0%LyGlycoprotein catabolism; cleaves the GlcNAc-Asn bond
       25 Lysosomal α-glucosidaseP10253105.31; 1.9%LyEssential for degradation of glycogen in lysosomes; Pompe disease
      Unknown
       26 High mobility group protein 1P0942924.79; 49.8%?Secreted or nuclear (
      • Muller S.
      • Scaffidi P.
      • Degryse B.
      • Bonaldi T.
      • Ronfani L.
      • Agresti A.
      • Beltrame M.
      • Bianchi M.E.
      New EMBO members’ review: the double life of HMGB1 chromatin protein: architectural factor and extracellular signal.
      ); gastrointestinal stromal tumor marker (
      • Choi Y.R.
      • Kim H.
      • Kang H.J.
      • Kim N.G.
      • Kim J.J.
      • Park K.S.
      • Paik Y.K.
      • Kim H.O.
      Overexpression of high mobility group box 1 in gastrointestinal stromal tumors with KIT mutation.
      )
       27 R31109_1 (25-kDa protein; similar to high mobility group 20B)Q9Y4A224.63; 22.5%?Similar to high mobility group protein 1
       28
      These proteins were not identified in all five neuromelanin granule preparations.
      Hypothetical protein LOC196463
      Q8NHP865.53;?
       29 25-kDa brain-specific proteinO9481123.713; 57.7%?Brain-specific expression; glycogen synthase kinase 3 (GSK3) inhibitor p24; p25 could act as a unique MAP in vivo (
      • Hlavanda E.
      • Kovacs J.
      • Olah J.
      • Orosz F.
      • Medzihradszky K.F.
      • Ovadi J.
      Brain-specific p25 protein binds to tubulin and microtubules and induces aberrant microtubule assemblies at substoichiometric concentrations.
      )
      Probable cytosolic proteins
       30 Mammalian ependymin-related protein-1 (MERP-1; UCC1 protein)Q9UM2219.95; 55.0%?Secreted
       31 Tyrosine 3-monooxygenase (tyrosine 3-hydroxylase)P0710158.53; 12.3%CytosolCatalyzes the first step in catecholamine biosynthesis; putatively involved in the synthesis of neuromelanin (
      • Haavik J.
      l-DOPA is a substrate for tyrosine hydroxylase.
      )
       32 14-3-3 protein ζ/δP2931227.72; 12.7%CytosolActivates tyrosine 3-hydroxylase
       33 14-3-3 Protein γP3521428.33; 13.4%CytosolActivates tyrosine 3-hydroxylase
       34
      These proteins were not identified in all five neuromelanin granule preparations.
      Peroxiredoxin 1
      Q0683022.13; 15.5%Ly, cytosolAntioxidant protection
       35 Heat shock cognate 71-kDa protein (heat shock 70-kDa protein 8)P1114253.54; 10.4%CytosolChaperone, protein folding; ATPase activity; maybe functions as an endogenous inhibitory regulator of hsc70
       36 α-Crystallin B chainP0251122.411; 76.8%Accumulates in the brains of patients with Alexander disease; HSP20 family
       37 Heat shock 70-kDa protein 9B (mortalin-2)Q8N1C873.73; 7.4%?Calcium and ATP binding; modulates toxicity of α-synuclein (
      • Zhou Y.
      • Gu G.
      • Goodlett D.R.
      • Zhang T.
      • Pan C.
      • Montine T.J.
      • Montine K.S.
      • Aebersold R.H.
      • Zhang J.
      Analysis of α-synuclein-associated proteins by quantitative proteomics.
      )
       38 Heat shock protein 90-αP0790084.65; 7.5%CytosolATPase activity (by similarity)
       39 Glycogen phosphorylase, brain formP1121696.75; 9.2%CytosolCarbohydrate metabolism
       40 6-PhosphofructokinaseP7845785.05; 9.9%CytosolGlycolysis
       41 Glyceraldehyde-3-phosphate dehydrogenase (GAPDH)P0440635.92; 9.6%CytosolGlycolysis
      Others
       42 UbiquitinP022488.6Proteasome- or lysosome-based protein degradation; protein transport to lysosomes
       43 Similar to cytosolic sialic acid 9-O-acetylesterase homologQ8IUT958.111; 38.8%Ly, E9-O-Acetylation of sialic acids, localized in lysosomes and endosomes
       44 Myelin basic proteinP0268621.517; 61.9%
       45
      These proteins were not identified in all five neuromelanin granule preparations.
      Myelin proteolipid protein (PLP)
      P6020130.12; 8.7%Integral membrane protein; Pelizaeus-Merzbacher disease
       46 2′,3′-Cyclic nucleotide 3′-phosphodiesteraseP0954347.68; 20.7%Bound to membrane structures of brain white matter, myelin-associated
       47
      These proteins were not identified in all five neuromelanin granule preparations.
      Sodium/potassium-transporting ATPase, α-3 chain
      P13637111.73; 6.0%PM, ESodium/potassium exchange; probably regulated by endocytosis (
      • Ogimoto G.
      • Yudowski G.A.
      • Barker C.J.
      • Kohler M.
      • Katz A.I.
      • Feraille E.
      • Pedemonte C.H.
      • Berggren P.O.
      • Bertorello A.M.
      G protein-coupled receptors regulate Na+,K+-ATPase activity and endocytosis by modulating the recruitment of adaptor protein 2 and clathrin.
      )
       48
      These proteins were not identified in all five neuromelanin granule preparations.
      Voltage-dependent anion-selective channel P (VDAC 1)
      P2179630.63; 18.1%Mt, E, LyAllows diffusion of small hydrophilic molecules
       49
      These proteins were not identified in all five neuromelanin granule preparations.
      Apolipoprotein D (apoD)
      P0509021.25; 21.2%Endocytosed; lipid metabolism
       50 Cystatin CP0103415.84; 40.9%Cysteine protease inhibitor; amyloidogenic properties
      Mitochondrial proteins
       51 Similar to ATP synthase, mitochondrial F1 complex, α subunitQ96FB459.84; 14.5%Mt, LyF1 ATPase subunit
       52 ATP synthase β chainP0657656.512; 42.9%MtF1 ATPase subunit
       53
      These proteins were not identified in all five neuromelanin granule preparations.
      ATP synthase D chain
      O594718.41; 12.4%MtF1 ATPase subunit
       54
      These proteins were not identified in all five neuromelanin granule preparations.
      ATP synthase g chain
      O7596411.41; 14.6%Mt, LyF1 ATPase subunit
       55 60-kDa heat shock protein (HSP60)P1080961.12; 7.7%MtMitochondrial matrix; protein folding
       56 Phospholipid-hydroperoxide glutathione peroxidase (PHGPx)P3696922.12; 13.2%Mt, cytosolProtects against oxidative damage and the toxicity of ingested lipid hydroperoxides
      Vesicular traffic
       57 Tubulin α 6Q9BQE349.94; 20.8%Major constituent of microtubules
       58 Tubulin β 2P0521749.85;19.8%Major constituent of microtubules
       59 Microtubule-associated protein 2P11137202.811;10.0%May stabilize the microtubules against depolymerization
       60 Microtubule-associated protein tauP1063678.72; 6.1%Microtubule assembly
       61 Clathrin heavy chainQ00610191.61; 1.1%Cytoplasmic face of coated pits and vesicles
       62 Phosphatidylinositol-binding clathrin assembly protein (CALM, AP180-2)Q1349270.71; 3.4%Assembly of clathrin, clathrin coated-vesicle formation; membrane recycling
       63
      These proteins were not identified in all five neuromelanin granule preparations.
      Phosphatidylinositol 4-phosphate 5-kinase type II α
      P4842646.22; 8.1%E, LyAssociated with membranes of the late endocytic pathway
       64
      These proteins were not identified in all five neuromelanin granule preparations.
      α-SNAP
      P549203; 14.2%VesiclesParticipates in various endocytotic events and vesicular traffic
       65
      These proteins were not identified in all five neuromelanin granule preparations.
      Syntaxin-binding protein 1 (Hunc18)
      P6176467.63; 7.9%VesiclesParticipates in various endocytotic events and vesicular traffic
       66 Dynamin-1, neural isoformQ0519397.43; 3.5%E, vesiclesParticipates in various endocytotic events and vesicular traffic
       67 NipSnap1 proteinQ9BPW833.33; 16.6%Vesicles?Putative involvement in vesicular traffic
       68 NipSnap2 proteinO7532333.84; 31.8%Vesicles?Transmembrane domain; putative involvement in vesicular traffic
      Endoplasmic reticulum
       69 CalreticulinP2779746.82; 7.2%ER, cytosol, ECMChaperone promoting folding, assembly, and quality control in the ER via the calreticulin/calnexin cycle; associated with the lytic granules
       70 Calnexin (p90)P2782467.64; 9.8%ERType I membrane protein; melanogenetic chaperone; not associated to classical lysosomes but to some lysosome-related organelles
       71 Dolichyl-diphosphooligosac-charide-protein glyco-syltransferase (ribophorin I)P0484368.63; 7.1%ERType I membrane protein; N-oligosaccharyltrans-ferase enzyme (transfer of a high mannose oligosaccharide from a lipid-linked donor to an asparagine residue)
       72 Protein-disulfide isomerase A3 (ERp57)P3010154.34; 12.0%ERProtein-disulfide isomerase family
      a These proteins were not identified in all five neuromelanin granule preparations.
      Figure thumbnail gr6
      Fig. 6.Examples of ESI-MS/MS spectra of proteins identified in NM granules.A, LIMP II; B, subunit A of the vacuolar ATPase; C, cathepsin D; D, calnexin.
      We found a variety of transmembrane proteins specific for organelles originating from the endosome-lysosome lineage, such as LIMP II (Protein 2) and LAMP-1 (Protein 3) but also subunits of the vacuolar ATPase (Proteins 4–6) responsible for the acidification of intracellular compartments (Fig. 6 and Table I). LIMP II was the only lysosomal marker membrane protein unequivocally identified by mass spectrometry. Although our analytical approach is compatible with membrane proteins (
      • Schafer H.
      • Nau K.
      • Sickmann A.
      • Erdmann R.
      • Meyer H.E.
      Identification of peroxisomal membrane proteins of Saccharomyces cerevisiae by mass spectrometry.
      ,
      • Santoni V.
      • Molloy M.
      • Rabilloud T.
      Membrane proteins and proteomics: un amour impossible?.
      ), LAMP-1 (Protein 3) and LAMP-3 (LIMP I) (Protein 1) could not be identified by a sufficient amount of peptides by mass spectrometry. As both proteins are glycosylated, LAMP-1 and -3 might be present in a much lower amount in NM granules than LIMP II. The presence of LAMP-1 was substantiated by Western blot analysis (Fig. 4A, e). We further identified several proteases known to be localized in the lysosome (e.g. cathepsin B (Protein 7) (Fig. 4A, d), cathepsin D (Protein 8), and tripeptidyl-peptidase I (Protein 10)) and enzymes mediating the catabolism of sphingolipids or glycoproteins (e.g. acid ceramidase (Protein 15), palmitoyl protein thioesterase 1 (Protein 17), and chondroitinase (Protein 22)).
      We also identified a few proteins with unknown localization and function, especially of the high mobility group protein family (Proteins 26 and 27) but also some cytosolic proteins. Cytoskeletal components such as microtubule-associated protein 2 (Protein 59), tau protein (Protein 60), α-/β-tubulin (Proteins 57 and 58), necessary for vesicular traffic, were also identified. NM granules exhibit proteins that are involved in vesicular traffic and are associated to endosomal membranes, e.g. clathrin (Protein 61), phosphatidylinositol-binding clathrin assembly protein (Protein 62), and dynamin (Protein 66) (Fig. 4A, f and g) (
      • Hinrichsen L.
      • Harborth J.
      • Andrees L.
      • Weber K.
      • Ungewickell E.J.
      Effect of clathrin heavy chain- and α-adaptin-specific small inhibitory RNAs on endocytic accessory proteins and receptor trafficking in HeLa cells.
      • Iversen T.G.
      • Skretting G.
      • van Deurs B.
      • Sandvig K.
      Clathrin-coated pits with long, dynamin-wrapped necks upon expression of a clathrin antisense RNA.
      • Stoorvogel W.
      • Oorschot V.
      • Geuze H.J.
      A novel class of clathrin-coated vesicles budding from endosomes.
      ) but also α-soluble NSF attachment protein (α-SNAP) (Protein 64) and phosphatidylinositol-4-phosphate 5-kinase type II (Protein 63). γ-Glutamyl hydrolase (Protein 11) (peptidase family C26) and lysosomal sialic acid 9-O-acetylesterase (Protein 43) are likely to be localized in organelles derived from the endosome-lysosome lineage (
      • Butor C.
      • Higa H.H.
      • Varki A.
      Structural, immunological, and biosynthetic studies of a sialic acid-specific O-acetylesterase from rat liver.
      • Galivan J.
      • Ryan T.J.
      • Chave K.
      • Rhee M.
      • Yao R.
      • Yin D.
      Glutamyl hydrolase: pharmacological role and enzymatic characterization.
      • Takematsu H.
      • Diaz S.
      • Stoddart A.
      • Zhang Y.
      • Varki A.
      Lysosomal and cytosolic sialic acid 9-O-acetylesterase activities can be encoded by one gene via differential usage of a signal peptide-encoding exon at the N terminus.
      ).
      To further examine the lysosomal traits of NM granules, we used GNA, a mannose-binding lectin, to identify proteins targeted to lysosomal compartments. Because of their selective binding to glycan structures lectins are a powerful tool in the analysis of glycoproteins (
      • Hagglund P.
      • Bunkenborg J.
      • Elortza F.
      • Jensen O.N.
      • Roepstorff P.
      A new strategy for identification of N-glycosylated proteins and unambiguous assignment of their glycosylation sites using HILIC enrichment and partial deglycosylation.
      ,
      • Medzihradszky K.F.
      Characterization of site-specific glycosylation.
      ). As shown in Fig. 4B, numerous mannosylated proteins were found in NM granules and SN tissue homogenate. However, only a subset of mannosylated proteins was found in NM granules compared with the total tissue homogenate.
      Interesting findings, however, are the obvious presence of four ER-derived proteins (Proteins 69–72, most notably calnexin (Figs. 6 and 4A, h), whereas by Western immunoblotting we could not show the presence of the ER marker protein 78-kDa glucose-regulated protein (BiP/grp78) (Fig. 4A, i).

      DISCUSSION

      This study demonstrated the utility of a new approach to analyze purified NM granules that sheds light on the biogenesis and biology of these unique organelles. We developed a new method for isolation of intact and pure NM granules from human SN without using detergents, organic solvents, and proteases as applied in the isolation of NM from crude tissue homogenates (
      • Dzierzega-Lecznar A.
      • Kurkiewicz S.
      • Stepien K.
      • Chodurek E.
      • Wilczok T.
      • Arzberger T.
      • Riederer P.
      • Gerlach M.
      GC/MS analysis of thermally degraded neuromelanin from the human substantia nigra.
      ). Then we applied 1-D SDS-PAGE followed by in-gel digestion and nano-HPLC coupled to ESI-MS/MS to identify novel constituents of NM granules. This approach overcomes the difficulties in separation of basic and hydrophobic proteins as with two-dimensional electrophoresis (
      • Santoni V.
      • Molloy M.
      • Rabilloud T.
      Membrane proteins and proteomics: un amour impossible?.
      ,
      • Wu C.C.
      • Yates III, J.R.
      The application of mass spectrometry to membrane proteomics.
      ). In addition, we used Western immunoblot analysis to investigate the potential link to lysosomes. Table I summarizes the proteins identified by ESI-MS/MS. The function and the subcellular localization of some proteins identified by our approach are not yet entirely known.
      By using this approach we identified numerous proteins attributable to the endosome-lysosome lineage as well as four proteins from the ER. A link of NM granules to lysosomes has been assumed previously; however, the morphological appearance and the phylogenetic limitation of the pigment NM are their most striking differences to conventional lysosomes.
      In eukaryotic cells, lysosomes serve as the terminal sites for delivery of material targeted for removal (
      • Chataway T.K.
      • Whittle A.M.
      • Lewis M.D.
      • Bindloss C.A.
      • Moritz R.L.
      • Simpson R.J.
      • Hopwood J.J.
      • Meikle P.J.
      Development of a two-dimensional gel electrophoresis database of human lysosomal proteins.
      • de Duve C.
      Lysosomes revisited.
      • Kornfeld S.
      • Mellman I.
      The biogenesis of lysosomes.
      ). For this purpose, lysosomes are equipped with a variety of more than 50 soluble acid-dependent hydrolases engaged in final degradation of both exogenous and endogenous macromolecules. Lysosomes are highly dynamic and heterogeneous organelles and thus cannot be identified solely by morphology (
      • Bagshaw R.D.
      • Mahuran D.J.
      • Callahan J.W.
      A proteomic analysis of lysosomal integral membrane proteins reveals the diverse composition of the organelle.
      • Hunziker W.
      • Geuze H.J.
      Intracellular trafficking of lysosomal membrane proteins.
      • Luzio J.P.
      • Poupon V.
      • Lindsay M.R.
      • Mullock B.M.
      • Piper R.C.
      • Pryor P.R.
      Membrane dynamics and the biogenesis of lysosomes.
      • Mullins C.
      • Bonifacino J.S.
      The molecular machinery for lysosome biogenesis.
      ). Therefore, lysosomes are described by the presence of highly glycosylated integral membrane proteins known as LAMPs, LIMPs, and lysosomal membrane glycoproteins. In contrast to late endosomal compartments, they lack mannose 6-phosphate receptors. Lysosomes maintain an acidic pH (4.5–5.0) required for the hydrolytic activities of the luminal enzymes. All or most of these features are shared with specialized cell type-specific “lysosome-related organelles” including melanosomes, platelet-dense granules, lytic granules, and major histocompatibility complex class II compartments among others, which mostly perform physiological functions different from biomolecular degradation (
      • Dell’Angelica E.C.
      • Mullins C.
      • Caplan S.
      • Bonifacino J.S.
      Lysosome-related organelles.
      ). Various studies on genetic multiorganellar disorders substantiated the biogenetic relationship between lysosome-related organelles and lysosomes.
      Recently various models of lysosomal biogenesis have been established (
      • Hunziker W.
      • Geuze H.J.
      Intracellular trafficking of lysosomal membrane proteins.
      • Luzio J.P.
      • Poupon V.
      • Lindsay M.R.
      • Mullock B.M.
      • Piper R.C.
      • Pryor P.R.
      Membrane dynamics and the biogenesis of lysosomes.
      • Mullins C.
      • Bonifacino J.S.
      The molecular machinery for lysosome biogenesis.
      ), but all of them include the existence of very specific sorting mechanisms. Membrane proteins such as LAMP-1 and LIMP II exit the trans-Golgi network on a secretory route to the endosomal compartments that is mediated by recognition of their tyrosine-based (LAMP-1) and dileucine-based (LIMP II) sorting motifs (
      • Bonifacino J.S.
      • Traub L.M.
      Signals for sorting of transmembrane proteins to endosomes and lysosomes.
      • Dell’Angelica E.C.
      • Shotelersuk V.
      • Aguilar R.C.
      • Gahl W.A.
      • Bonifacino J.S.
      Altered trafficking of lysosomal proteins in Hermansky-Pudlak syndrome due to mutations in the β 3A subunit of the AP-3 adaptor.
      • Honing S.
      • Sandoval I.V.
      • von Figura K.
      A di-leucine-based motif in the cytoplasmic tail of LIMP-II and tyrosinase mediates selective binding of AP-3.
      • Obermuller S.
      • Kiecke C.
      • von Figura K.
      • Honing S.
      The tyrosine motifs of Lamp 1 and LAP determine their direct and indirect targeting to lysosomes.
      ) by adaptor complex AP-3 (
      • Dell’Angelica E.C.
      • Shotelersuk V.
      • Aguilar R.C.
      • Gahl W.A.
      • Bonifacino J.S.
      Altered trafficking of lysosomal proteins in Hermansky-Pudlak syndrome due to mutations in the β 3A subunit of the AP-3 adaptor.
      ). This adaptor complex AP-3 is also crucial for the biogenesis of lysosome-related melanosomes by targeting tyrosinase gene family proteins according to their dileucine-based sorting motifs (
      • Jimbow K.
      • Park J.S.
      • Kato F.
      • Hirosaki K.
      • Toyofuku K.
      • Hua C.
      • Yamashita T.
      Assembly, target-signaling and intracellular transport of tyrosinase gene family proteins in the initial stage of melanosome biogenesis.
      ). However, in our study on NM granules we did not find the melanogenic enzymes tyrosinase and tyrosinase-related proteins 1 and 2, which are located in melanosomes of cutaneous melanocytes and retinal pigment epithelial cells. Although low levels of tyrosinase mRNA have been reported in human SN (
      • Xu Y.
      • Stokes A.H.
      • Freeman W.M.
      • Kumer S.C.
      • Vogt B.A.
      • Vrana K.E.
      Tyrosinase mRNA is expressed in human substantia nigra.
      ), tyrosinase protein does not appear to be expressed in the human brain (
      • Ikemoto K.
      • Nagatsu I.
      • Ito S.
      • King R.A.
      • Nishimura A.
      • Nagatsu T.
      Does tyrosinase exist in neuromelanin-pigmented neurons in the human substantia nigra?.
      ).
      F. Tribl, M. Gerlach, T. Arzberger, and P. Riederer, unpublished observation.
      The current evidence thus suggests that tyrosinase does not appear to have a role in the synthesis of human brain NM. Regardless it cannot be excluded that such an enzyme is covalently bound to the framework of the highly abundant pigment, which renders the protein insoluble and inaccessible to detergents (
      • Zeise L.
      • Murr B.L.
      • Chedekel M.R.
      Melanin standard method: particle description.
      ).
      In the context of membrane protein sorting, we want to point out that surprisingly we did not detect the “classical” lysosomal marker protein lysosomal acid phosphatase. At first, lysosomal acid phosphatase is transiently integrated into the limiting membrane as a type I membrane protein and is further proteolytically processed to gradually release the luminal active site of the enzyme into the lysosomal matrix (
      • Waheed A.
      • Gottschalk S.
      • Hille A.
      • Krentler C.
      • Pohlmann R.
      • Braulke T.
      • Hauser H.
      • Geuze H.
      • von Figura K.
      Human lysosomal acid phosphatase is transported as a transmembrane protein to lysosomes in transfected baby hamster kidney cells.
      ).
      A distinct pathway guides mannose 6-phosphate-tagged acid-dependent hydrolases to endosomes and lysosomes in clathrin-coated vesicles, which bud from the trans-Golgi network as the mannose 6-phosphate tag is recognized by mannose 6-phosphate receptors. Dynamin has been suggested recently to be associated with late endosomes, tubulovesicles, and clathrin-coated vesicles as well as being involved in the recycling of mannose 6-phosphate receptors after cargo delivery (
      • Nicoziani P.
      • Vilhardt F.
      • Llorente A.
      • Hilout L.
      • Courtoy P.J.
      • Sandvig K.
      • van Deurs B.
      Role for dynamin in late endosome dynamics and trafficking of the cation-independent mannose 6-phosphate receptor.
      ). Interestingly by proteomic mapping we identified an unexpectedly small repertoire of mannosylated lysosomal enzymes (Table I), such as glycosyl hydrolases (EC 3.2.1.) (
      • Journet A.
      • Chapel A.
      • Kieffer S.
      • Roux F.
      • Garin J.
      Proteomic analysis of human lysosomes: application to monocytic and breast cancer cells.
      ). Again a similar situation occurred showing a small subset of proteins when tested for mannosylation by GNA recognition (Fig. 4B).
      A few proteins specifically facilitating the degradation of glycosphingolipids (
      • Sandhoff K.
      • Kolter T.
      • Van Echten-Deckert G.
      Sphingolipid metabolism. Sphingoid analogs, sphingolipid activator proteins, and the pathology of the cell.
      ) were identified, such as acid ceramidase, etc. (Table I). Glycosphingolipids are predominantly found in neuronal tissue; it will be the task of further investigations to elucidate whether or not sphingolipids are found in the lipidic bulbs of the NM granules. Mutated forms of tripeptidyl-peptidase I (Protein 10) and dipeptidyl-peptidase II (Protein 14) have been found to be involved in some types of neuronal ceroid lipofuscinosis, characterized by an accumulation of autofluorescent inclusion bodies (
      • Mole S.E.
      • Mitchison H.M.
      • Munroe P.B.
      Molecular basis of the neuronal ceroid lipofuscinoses: mutations in CLN1, CLN2, CLN3, and CLN5.
      ). These forms of neurodegenerative disorders are regarded as lysosomal storage diseases evoked by defective proteolysis.
      Our findings of ER proteins associated with NM granules substantiate their multitopological subcellular localization. We assume a specific localization of the ER proteins in NM granules because major ER constituents, e.g. cytochrome P-450 isoforms or NADPH cytochrome c reductase (
      • Fengsrud M.
      • Erichsen E.S.
      • Berg T.O.
      • Raiborg C.
      • Seglen P.O.
      Ultrastructural characterization of the delimiting membranes of isolated autophagosomes and amphisomes by freeze-fracture electron microscopy.
      ), have not been detected, and we could not identify BiP/grp78 by MS and Western immunoblotting (Fig. 4B). This is in line with recent findings that suggest a direct involvement of the ER in the establishment of early lysosomal structures including phagosomes in neutrophiles (
      • Garin J.
      • Diez R.
      • Kieffer S.
      • Dermine J.F.
      • Duclos S.
      • Gagnon E.
      • Sadoul R.
      • Rondeau C.
      • Desjardins M.
      The phagosome proteome: insight into phagosome functions.
      ) and stage I melanosomes in melanocytes (
      • Basrur V.
      • Yang F.
      • Kushimoto T.
      • Higashimoto Y.
      • Yasumoto K.
      • Valencia J.
      • Muller J.
      • Vieira W.D.
      • Watabe H.
      • Shabanowitz J.
      • Hearing V.J.
      • Hunt D.F.
      • Appella E.
      Proteomic analysis of early melanosomes: identification of novel melanosomal proteins.
      ,
      • Dell’Angelica E.C.
      Melanosome biogenesis: shedding light on the origin of an obscure organelle.
      ). During the maturation of phagosomes to phagolysosomes the quantity of ER proteins gradually decreases; calnexin especially is lost rapidly (
      • Gagnon E.
      • Duclos S.
      • Rondeau C.
      • Chevet E.
      • Cameron P.H.
      • Steele-Mortimer O.
      • Paiement J.
      • Bergeron J.J.
      • Desjardins M.
      Endoplasmic reticulum-mediated phagocytosis is a mechanism of entry into macrophages.
      ). In classical lysosomes calnexin is absent but is rather associated with lysosome-related organelles such as melanosomes (
      • Dakour J.
      • Vinayagamoorthy T.
      • Jimbow K.
      • Chen H.
      • Luo D.
      • Dixon W.
      • Munoz V.
      Identification of a cDNA coding for a Ca2+-binding phosphoprotein (p90), calnexin, on melanosomes in normal and malignant human melanocytes.
      • Salopek T.G.
      • Jimbow K.
      Induction of melanogenesis during the various melanoma growth phases and the role of tyrosinase, lysosome-associated membrane proteins, and p90 calnexin in the melanogenesis cascade.
      • Toyofuku K.
      • Wada I.
      • Hirosaki K.
      • Park J.S.
      • Hori Y.
      • Jimbow K.
      Promotion of tyrosinase folding in COS 7 cells by calnexin.
      ). There is increasing evidence that calnexin functions as a melanogenic chaperone (
      • Jimbow K.
      • Park J.S.
      • Kato F.
      • Hirosaki K.
      • Toyofuku K.
      • Hua C.
      • Yamashita T.
      Assembly, target-signaling and intracellular transport of tyrosinase gene family proteins in the initial stage of melanosome biogenesis.
      ,
      • Jimbow K.
      • Hara H.
      • Vinayagamoorthy T.
      • Luo D.
      • Dakour J.
      • Yamada K.
      • Dixon W.
      • Chen H.
      Molecular control of melanogenesis in malignant melanoma: functional assessment of tyrosinase and lamp gene families by UV exposure and gene co-transfection, and cloning of a cDNA encoding calnexin, a possible melanogenesis “chaperone.”.
      ) currently suggested to mediate the proper folding and sorting of the melanogenic enzymes toward their target compartment (
      • Toyofuku K.
      • Wada I.
      • Hirosaki K.
      • Park J.S.
      • Hori Y.
      • Jimbow K.
      Promotion of tyrosinase folding in COS 7 cells by calnexin.
      ,
      • Hasegawa T.
      • Matsuzaki M.
      • Takeda A.
      • Kikuchi A.
      • Furukawa K.
      • Shibahara S.
      • Itoyama Y.
      Increased dopamine and its metabolites in SH-SY5Y neuroblastoma cells that express tyrosinase.
      ).
      In summary, our results provided important insight into the cellular machinery used to generate NM granules, revealing an admirable conservation of cellular processes. At this stage of analysis, it has become clear that the majority of the components of NM granules, similar to those of melanosomes, are shared with lysosomes (Fig. 7). The putative precursor compartment may have endosomal traits; however, an additional direct involvement of the ER is suggested to contribute to the constitution of NM granules. Future studies are warranted to clarify the nature of the lipidic bulbs attached to NM granules.
      Figure thumbnail gr7
      Fig. 7.Schematic model of a proposed biogenetic pathway of NM granules.sim., similar; TPP-I, tripeptidyl-peptidase I; DPP-II, dipeptidyl-peptidase II; MAP-2, microtubule-associated protein 2; MERP-1/UCC1, mammalian ependymin-related protein-1/up-regulated in colorectal cancer gene-1.

      Acknowledgments

      We thank Siglinde Schenk for valuable advice and assistance with the electron microscopy work and Dr. Anne Price Mortimer for critically reading the manuscript.

      REFERENCES

        • Prota G.
        Melanins and Melanogenesis.
        Academic Press Inc., San Diego, CA1992
        • Lillie R.D.
        Metal reduction reactions of the melanins: histochemical studies.
        J. Histochem. Cytochem. 1957; 5: 325-333
        • Hirsch E.
        • Graybiel A.M.
        • Agid Y.A.
        Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson’s disease.
        Nature. 1988; 334: 345-348
        • Jellinger K.
        • Kienzl E.
        • Rumpelmair G.
        • Riederer P.
        • Stachelberger H.
        • Ben-Shachar D.
        • Youdim M.B.
        Iron-melanin complex in substantia nigra of parkinsonian brains: an x-ray microanalysis.
        J. Neurochem. 1992; 59: 1168-1171
        • Fasano M.
        • Giraudo S.
        • Coha S.
        • Bergamasco B.
        • Lopiano L.
        Residual substantia nigra neuromelanin in Parkinson’s disease is cross-linked to α-synuclein.
        Neurochem. Int. 2003; 42: 603-606
        • Double K.L.
        • Ben-Shachar D.
        • Youdim M.B.
        • Zecca L.
        • Riederer P.
        • Gerlach M.
        Influence of neuromelanin on oxidative pathways within the human substantia nigra.
        Neurotoxicol. Teratol. 2002; 24: 621-628
        • McRitchie D.A.
        • Halliday G.M.
        • Cartwright H.
        Quantitative analysis of the variability of substantia nigra pigmented cell clusters in the human.
        Neuroscience. 1995; 68: 539-551
        • Double K.L.
        • Zecca L.
        • Costi P.
        • Mauer M.
        • Griesinger C.
        • Ito S.
        • Ben-Shachar D.
        • Bringmann G.
        • Fariello R.G.
        • Riederer P.
        • Gerlach M.
        Structural characteristics of human substantia nigra neuromelanin and synthetic dopamine melanins.
        J. Neurochem. 2000; 75: 2583-2589
        • Dzierzega-Lecznar A.
        • Kurkiewicz S.
        • Stepien K.
        • Chodurek E.
        • Wilczok T.
        • Arzberger T.
        • Riederer P.
        • Gerlach M.
        GC/MS analysis of thermally degraded neuromelanin from the human substantia nigra.
        J. Am. Soc. Mass Spectrom. 2004; 15: 920-926
        • Zecca L.
        • Costi P.
        • Mecacci C.
        • Ito S.
        • Terreni M.
        • Sonnino S.
        Interaction of human substantia nigra neuromelanin with lipids and peptides.
        J. Neurochem. 2000; 74: 1758-1765
        • Fedorow H.
        • Pickford R.
        • Hook J.M.
        • Double K.L.
        • Halliday G.M.
        • Gerlach M.
        • Riederer P.
        • Garner B.
        Dolichol is the major lipid component of human substantia nigra neuromelanin.
        J. Neurochem. 2005; 92: 990-995
        • Fedorow H.
        • Tribl F.
        • Halliday G.
        • Gerlach M.
        • Riederer P.
        • Double K.L.
        Neuromelanin in human dopamine neurons: comparison with peripheral melanins and relevance to Parkinson’s disease.
        Prog. Neurobiol. 2005; 75: 109-124
        • Zecca L.
        • Tampellini D.
        • Gerlach M.
        • Riederer P.
        • Fariello R.G.
        • Sulzer D.
        Substantia nigra neuromelanin: structure, synthesis, and molecular behaviour.
        Mol. Pathol. 2001; 54: 414-418
        • Basrur V.
        • Yang F.
        • Kushimoto T.
        • Higashimoto Y.
        • Yasumoto K.
        • Valencia J.
        • Muller J.
        • Vieira W.D.
        • Watabe H.
        • Shabanowitz J.
        • Hearing V.J.
        • Hunt D.F.
        • Appella E.
        Proteomic analysis of early melanosomes: identification of novel melanosomal proteins.
        J. Proteome Res. 2003; 2: 69-79
        • Duffy P.E.
        • Tennyson V.M.
        Phase and electron microscopic observations of Lewy bodies and melanin granules in the substantia nigra and locus caeruleus in Parkinson’s disease.
        J. Neuropathol. Exp. Neurol. 1965; 24: 398-414
        • Moses H.L.
        • Ganote C.E.
        • Beaver D.L.
        • Schuffman S.S.
        Light and electron microscopic studies of pigment in human and rhesus monkey substantia nigra and locus coeruleus.
        Anat. Rec. 1966; 155: 167-183
        • Barden H.
        The histochemical relationship of neuromelanin and lipofuscin.
        J. Neuropathol. Exp. Neurol. 1969; 28: 419-441
        • Aebersold R.
        • Mann M.
        Mass spectrometry-based proteomics.
        Nature. 2003; 422: 198-207
        • Binz P.A.
        • Hochstrasser D.F.
        • Appel R.D.
        Mass spectrometry-based proteomics: current status and potential use in clinical chemistry.
        Clin. Chem. Lab. Med. 2003; 41: 1540-1551
        • Jung E.
        • Heller M.
        • Sanchez J.C.
        • Hochstrasser D.F.
        Proteomics meets cell biology: the establishment of subcellular proteomes.
        Electrophoresis. 2000; 21: 3369-3377
        • Reynolds E.S.
        The use of lead citrate at high pH as an electron-opaque stain in electron microscopy.
        J. Cell Biol. 1963; 17: 208-212
        • Neuhoff V.
        • Arold N.
        • Taube D.
        • Ehrhardt W.
        Improved staining of proteins in polyacrylamide gels including isoelectric focusing gels with clear background at nanogram sensitivity using Coomassie Brilliant Blue G-250 and R-250.
        Electrophoresis. 1988; 9: 255-262
        • Liao Y.F.
        • Lal A.
        • Moremen K.W.
        Cloning, expression, purification, and characterization of the human broad specificity lysosomal acid α-mannosidase.
        J. Biol. Chem. 1996; 271: 28348-28358
        • Shibuya N.
        • Goldstein I.J.
        • Van Damme E.J.
        • Peumans W.J.
        Binding properties of a mannose-specific lectin from the snowdrop (Galanthus nivalis) bulb.
        J. Biol. Chem. 1988; 263: 728-734
        • Schafer H.
        • Nau K.
        • Sickmann A.
        • Erdmann R.
        • Meyer H.E.
        Identification of peroxisomal membrane proteins of Saccharomyces cerevisiae by mass spectrometry.
        Electrophoresis. 2001; 22: 2955-2968
        • Marcus K.
        • Moebius J.
        • Meyer H.E.
        Differential analysis of phosphorylated proteins in resting and thrombin-stimulated human platelets.
        Anal. Bioanal. Chem. 2003; 376: 973-993
        • Eng J.K.
        • McCormack A.L.
        • Yates III, J.R.
        An approach to correlate tandem mass-spectral data of peptides with amino-acid-sequences in a protein database.
        J. Am. Soc. Mass Spectrom. 1994; 5: 976-989
        • Yates III, J.R.
        • Eng J.K.
        • McCormack A.L.
        • Schieltz D.
        Method to correlate tandem mass spectra of modified peptides to amino acid sequences in the protein database.
        Anal. Chem. 1995; 67: 1426-1436
        • Rogers S.L.
        • Tint I.S.
        • Fanapour P.C.
        • Gelfand V.I.
        Regulated bidirectional motility of melanophore pigment granules along microtubules in vitro.
        Proc. Natl. Acad. Sci. U. S. A. 1997; 94: 3720-3725
        • Testorf M.F.
        • Roback K.
        • Lundstrom I.
        • Svensson S.P.
        Volume changes of individual melanosomes measured by scanning force microscopy.
        Pigm. Cell Res. 2001; 14: 445-449
        • Hirosawa K.
        Electron microscopic studies on pigment granules in the substantia nigra and locus coeruleus of the Japanese monkey (Macaca fuscata yakui).
        Z. Zellforsch. Mikrosk. Anat. 1968; 88: 187-203
        • Santoni V.
        • Molloy M.
        • Rabilloud T.
        Membrane proteins and proteomics: un amour impossible?.
        Electrophoresis. 2000; 21: 1054-1070
        • Hinrichsen L.
        • Harborth J.
        • Andrees L.
        • Weber K.
        • Ungewickell E.J.
        Effect of clathrin heavy chain- and α-adaptin-specific small inhibitory RNAs on endocytic accessory proteins and receptor trafficking in HeLa cells.
        J. Biol. Chem. 2003; 278: 45160-45170
        • Iversen T.G.
        • Skretting G.
        • van Deurs B.
        • Sandvig K.
        Clathrin-coated pits with long, dynamin-wrapped necks upon expression of a clathrin antisense RNA.
        Proc. Natl. Acad. Sci. U. S. A. 2003; 100: 5175-5180
        • Stoorvogel W.
        • Oorschot V.
        • Geuze H.J.
        A novel class of clathrin-coated vesicles budding from endosomes.
        J. Cell Biol. 1996; 132: 21-33
        • Butor C.
        • Higa H.H.
        • Varki A.
        Structural, immunological, and biosynthetic studies of a sialic acid-specific O-acetylesterase from rat liver.
        J. Biol. Chem. 1993; 268: 10207-10213
        • Galivan J.
        • Ryan T.J.
        • Chave K.
        • Rhee M.
        • Yao R.
        • Yin D.
        Glutamyl hydrolase: pharmacological role and enzymatic characterization.
        Pharmacol. Ther. 2000; 85: 207-215
        • Takematsu H.
        • Diaz S.
        • Stoddart A.
        • Zhang Y.
        • Varki A.
        Lysosomal and cytosolic sialic acid 9-O-acetylesterase activities can be encoded by one gene via differential usage of a signal peptide-encoding exon at the N terminus.
        J. Biol. Chem. 1999; 274: 25623-25631
        • Hagglund P.
        • Bunkenborg J.
        • Elortza F.
        • Jensen O.N.
        • Roepstorff P.
        A new strategy for identification of N-glycosylated proteins and unambiguous assignment of their glycosylation sites using HILIC enrichment and partial deglycosylation.
        J. Proteome Res. 2004; 3: 556-566
        • Medzihradszky K.F.
        Characterization of site-specific glycosylation.
        Methods Mol. Biol. 2002; 194: 101-125
        • Wu C.C.
        • Yates III, J.R.
        The application of mass spectrometry to membrane proteomics.
        Nat. Biotechnol. 2003; 21: 262-267
        • Chataway T.K.
        • Whittle A.M.
        • Lewis M.D.
        • Bindloss C.A.
        • Moritz R.L.
        • Simpson R.J.
        • Hopwood J.J.
        • Meikle P.J.
        Development of a two-dimensional gel electrophoresis database of human lysosomal proteins.
        Electrophoresis. 1998; 19: 834-836
        • de Duve C.
        Lysosomes revisited.
        Eur. J. Biochem. 1983; 137: 391-397
        • Kornfeld S.
        • Mellman I.
        The biogenesis of lysosomes.
        Annu. Rev. Cell Biol. 1989; 5: 483-525
        • Bagshaw R.D.
        • Mahuran D.J.
        • Callahan J.W.
        A proteomic analysis of lysosomal integral membrane proteins reveals the diverse composition of the organelle.
        Mol Cell. Proteomics. 2005; 4: 133-143
        • Hunziker W.
        • Geuze H.J.
        Intracellular trafficking of lysosomal membrane proteins.
        Bioessays. 1996; 18: 379-389
        • Luzio J.P.
        • Poupon V.
        • Lindsay M.R.
        • Mullock B.M.
        • Piper R.C.
        • Pryor P.R.
        Membrane dynamics and the biogenesis of lysosomes.
        Mol. Membr. Biol. 2003; 20: 141-154
        • Mullins C.
        • Bonifacino J.S.
        The molecular machinery for lysosome biogenesis.
        Bioessays. 2001; 23: 333-343
        • Dell’Angelica E.C.
        • Mullins C.
        • Caplan S.
        • Bonifacino J.S.
        Lysosome-related organelles.
        FASEB J. 2000; 14: 1265-1278
        • Bonifacino J.S.
        • Traub L.M.
        Signals for sorting of transmembrane proteins to endosomes and lysosomes.
        Annu. Rev. Biochem. 2003; 72: 395-447
        • Dell’Angelica E.C.
        • Shotelersuk V.
        • Aguilar R.C.
        • Gahl W.A.
        • Bonifacino J.S.
        Altered trafficking of lysosomal proteins in Hermansky-Pudlak syndrome due to mutations in the β 3A subunit of the AP-3 adaptor.
        Mol. Cell. 1999; 3: 11-21
        • Honing S.
        • Sandoval I.V.
        • von Figura K.
        A di-leucine-based motif in the cytoplasmic tail of LIMP-II and tyrosinase mediates selective binding of AP-3.
        EMBO J. 1998; 17: 1304-1314
        • Obermuller S.
        • Kiecke C.
        • von Figura K.
        • Honing S.
        The tyrosine motifs of Lamp 1 and LAP determine their direct and indirect targeting to lysosomes.
        J. Cell Sci. 2002; 115: 185-194
        • Jimbow K.
        • Park J.S.
        • Kato F.
        • Hirosaki K.
        • Toyofuku K.
        • Hua C.
        • Yamashita T.
        Assembly, target-signaling and intracellular transport of tyrosinase gene family proteins in the initial stage of melanosome biogenesis.
        Pigm. Cell Res. 2000; 13: 222-229
        • Xu Y.
        • Stokes A.H.
        • Freeman W.M.
        • Kumer S.C.
        • Vogt B.A.
        • Vrana K.E.
        Tyrosinase mRNA is expressed in human substantia nigra.
        Brain Res. Mol. Brain Res. 1997; 45: 159-162
        • Ikemoto K.
        • Nagatsu I.
        • Ito S.
        • King R.A.
        • Nishimura A.
        • Nagatsu T.
        Does tyrosinase exist in neuromelanin-pigmented neurons in the human substantia nigra?.
        Neurosci. Lett. 1998; 253: 198-200
        • Ogimoto G.
        • Yudowski G.A.
        • Barker C.J.
        • Kohler M.
        • Katz A.I.
        • Feraille E.
        • Pedemonte C.H.
        • Berggren P.O.
        • Bertorello A.M.
        G protein-coupled receptors regulate Na+,K+-ATPase activity and endocytosis by modulating the recruitment of adaptor protein 2 and clathrin.
        Proc. Natl. Acad. Sci. U. S. A. 2000; 97: 3242-3247
        • Zeise L.
        • Murr B.L.
        • Chedekel M.R.
        Melanin standard method: particle description.
        Pigm. Cell Res. 1992; 5: 132-142
        • Waheed A.
        • Gottschalk S.
        • Hille A.
        • Krentler C.
        • Pohlmann R.
        • Braulke T.
        • Hauser H.
        • Geuze H.
        • von Figura K.
        Human lysosomal acid phosphatase is transported as a transmembrane protein to lysosomes in transfected baby hamster kidney cells.
        EMBO J. 1988; 7: 2351-2358
        • Nicoziani P.
        • Vilhardt F.
        • Llorente A.
        • Hilout L.
        • Courtoy P.J.
        • Sandvig K.
        • van Deurs B.
        Role for dynamin in late endosome dynamics and trafficking of the cation-independent mannose 6-phosphate receptor.
        Mol. Biol. Cell. 2000; 11: 481-495
        • Journet A.
        • Chapel A.
        • Kieffer S.
        • Roux F.
        • Garin J.
        Proteomic analysis of human lysosomes: application to monocytic and breast cancer cells.
        Proteomics. 2002; 2: 1026-1040
        • Sandhoff K.
        • Kolter T.
        • Van Echten-Deckert G.
        Sphingolipid metabolism. Sphingoid analogs, sphingolipid activator proteins, and the pathology of the cell.
        Ann. N. Y. Acad. Sci. 1998; 845: 139-151
        • Mole S.E.
        • Mitchison H.M.
        • Munroe P.B.
        Molecular basis of the neuronal ceroid lipofuscinoses: mutations in CLN1, CLN2, CLN3, and CLN5.
        Hum. Mutat. 1999; 14: 199-215
        • Fengsrud M.
        • Erichsen E.S.
        • Berg T.O.
        • Raiborg C.
        • Seglen P.O.
        Ultrastructural characterization of the delimiting membranes of isolated autophagosomes and amphisomes by freeze-fracture electron microscopy.
        Eur. J. Cell Biol. 2000; 79: 871-882
        • Garin J.
        • Diez R.
        • Kieffer S.
        • Dermine J.F.
        • Duclos S.
        • Gagnon E.
        • Sadoul R.
        • Rondeau C.
        • Desjardins M.
        The phagosome proteome: insight into phagosome functions.
        J. Cell Biol. 2001; 152: 165-180
        • Dell’Angelica E.C.
        Melanosome biogenesis: shedding light on the origin of an obscure organelle.
        Trends Cell Biol. 2003; 13: 503-506
        • Gagnon E.
        • Duclos S.
        • Rondeau C.
        • Chevet E.
        • Cameron P.H.
        • Steele-Mortimer O.
        • Paiement J.
        • Bergeron J.J.
        • Desjardins M.
        Endoplasmic reticulum-mediated phagocytosis is a mechanism of entry into macrophages.
        Cell. 2002; 110: 119-131
        • Dakour J.
        • Vinayagamoorthy T.
        • Jimbow K.
        • Chen H.
        • Luo D.
        • Dixon W.
        • Munoz V.
        Identification of a cDNA coding for a Ca2+-binding phosphoprotein (p90), calnexin, on melanosomes in normal and malignant human melanocytes.
        Exp. Cell Res. 1993; 209: 288-300
        • Salopek T.G.
        • Jimbow K.
        Induction of melanogenesis during the various melanoma growth phases and the role of tyrosinase, lysosome-associated membrane proteins, and p90 calnexin in the melanogenesis cascade.
        J. Investig. Dermatol. Symp. Proc. 1996; 1: 195-202
        • Toyofuku K.
        • Wada I.
        • Hirosaki K.
        • Park J.S.
        • Hori Y.
        • Jimbow K.
        Promotion of tyrosinase folding in COS 7 cells by calnexin.
        J. Biochem. (Tokyo). 1999; 125: 82-89
        • Jimbow K.
        • Hara H.
        • Vinayagamoorthy T.
        • Luo D.
        • Dakour J.
        • Yamada K.
        • Dixon W.
        • Chen H.
        Molecular control of melanogenesis in malignant melanoma: functional assessment of tyrosinase and lamp gene families by UV exposure and gene co-transfection, and cloning of a cDNA encoding calnexin, a possible melanogenesis “chaperone.”.
        J. Dermatol. 1994; 21: 894-906
        • Hasegawa T.
        • Matsuzaki M.
        • Takeda A.
        • Kikuchi A.
        • Furukawa K.
        • Shibahara S.
        • Itoyama Y.
        Increased dopamine and its metabolites in SH-SY5Y neuroblastoma cells that express tyrosinase.
        J. Neurochem. 2003; 87: 470-475
        • Muller S.
        • Scaffidi P.
        • Degryse B.
        • Bonaldi T.
        • Ronfani L.
        • Agresti A.
        • Beltrame M.
        • Bianchi M.E.
        New EMBO members’ review: the double life of HMGB1 chromatin protein: architectural factor and extracellular signal.
        EMBO J. 2001; 20: 4337-4340
        • Choi Y.R.
        • Kim H.
        • Kang H.J.
        • Kim N.G.
        • Kim J.J.
        • Park K.S.
        • Paik Y.K.
        • Kim H.O.
        Overexpression of high mobility group box 1 in gastrointestinal stromal tumors with KIT mutation.
        Cancer Res. 2003; 63: 2188-2193
        • Hlavanda E.
        • Kovacs J.
        • Olah J.
        • Orosz F.
        • Medzihradszky K.F.
        • Ovadi J.
        Brain-specific p25 protein binds to tubulin and microtubules and induces aberrant microtubule assemblies at substoichiometric concentrations.
        Biochemistry. 2002; 41: 8657-8664
        • Haavik J.
        l-DOPA is a substrate for tyrosine hydroxylase.
        J. Neurochem. 1997; 69: 1720-1728
        • Zhou Y.
        • Gu G.
        • Goodlett D.R.
        • Zhang T.
        • Pan C.
        • Montine T.J.
        • Montine K.S.
        • Aebersold R.H.
        • Zhang J.
        Analysis of α-synuclein-associated proteins by quantitative proteomics.
        J. Biol. Chem. 2004; 279: 39155-39164